How to boost clinical trial access and make patients health-empowered
September 17, 2024 | Activated Patient, Inclusion, Patient Participation, Patient-centricity, Pharma, clinical trials
Clinical research is becoming more patient-centric, but there’s still more that needs to be done to make clinical trials available to everyone. This could include wider participation.
How to increase patient participation
Pharmaceutical companies are working on overturning this statistic by designing and building trials that centre around participant needs. This includes greater patient involvement in trial design; more opportunities for treatment at home; fewer tests and assessments; and new technologies for support and monitoring.
However, it seems clinical trial participation is not for everyone. Could it be because a huge amount of trust, awareness and understanding is needed to become a clinical trial participant?
Where the ‘activated’ patient comes in
According to health researcher Judith Hibbard, activated patients, who are actively engaged in managing their health and advocating for themselves, are better equipped to handle health conditions and contribute to treatment decisions.
Although, it’s not always an equal starting point because not everyone will be at activated status. Because initiatives often engage with those who are already activated and have high levels of health literacy, The complexity of clinical trial information means that some patients defer decision-making to their doctors. It may not be on purpose, but this excludes many from potentially life-changing medicines.
Empower patients through clinical trials
This may be an opportunity for those in charge of clinical trials to take a leading role in helping patients to become activated, creating a push-pull that works in all directions. Consider clinical trial education and awareness resources developed with everyone in mind, helping to bridge the knowledge gap and supporting people to make informed decisions for their own health.
Shift towards community-inclusive trials
The industry is already beginning to shift towards more patient-centred clinical trial recruitment and providing trial information that speaks to all. But that’s just the start. Perhaps it’s time to bring whole communities into contact with the clinical research world instead, giving everyone an opportunity to share their opinions and ideas —, a chance to feel part of something bigger.
It might not be easy, but it will be worth it.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
From text to context: Helping patients see side effects clearly
Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.
Why patient engagement must come first in rare disease trials
Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients’ lives to build trust and improve outcomes.
New Cuttsy+Cuttsy research shows why site support matters more than ever
Cuttsy+Cuttsy’s upcoming report, ‘The site factor: Where protocol meets practice in clinical trials’, delves into the critical role of site staff in clinical research, offering insights into their daily challenges,…
Cuttsy+Cuttsy becomes employee owned
Cuttsy+Cuttsy announces its transition to employee ownership, celebrating 15 years of prioritising clients, patients, and its team while continuing under the leadership of founders Caroline Benson and Mathew Cutts.
Clinical research in 2026: The trends shaping tomorrow
Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections.
From overwhelming to actionable: Bringing lifestyle guidance to life
Discover how clear communication and health literacy principles can transform complex patient materials into simple, engaging, and empowering health information.
Behind the scenes: why we created ‘The participation equation’
Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research.
Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success
Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.
New report, The participation equation, uncovers key drivers of patient engagement in clinical trials
Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.
Why patients drop out of weight management trials and what you can do about it
Discover the key barriers to retention in obesity and weight-management trials and explore actionable, patient-centered strategies to improve engagement, outcomes, and data reliability.